Plant ID: NPO490
Plant Latin Name: Lophozonia menziesii
Taxonomy Genus: Lophozonia
Taxonomy Family: Nothofagaceae
NCBI TaxonomyDB:
28945
Plant-of-the-World-Online:
n.a.
TDP1; | |
ACHE; | |
PPARA; | |
TLR2; | |
MAPT; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 6.752E-07 | 7.351E-03 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.687E-06 | 1.225E-02 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 2.362E-06 | 1.286E-02 | CYP1A2, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 7.417E-06 | 2.019E-02 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 7.417E-06 | 2.019E-02 | CYP1A2, CYP3A4 |
BP | GO:0002376; immune system process | GO:0001774; microglial cell activation | 1.527E-05 | 3.695E-02 | MAPT, TLR2 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 2.838E-05 | 5.617E-02 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006706; steroid catabolic process | 3.644E-05 | 5.667E-02 | CYP1A2, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.106E-04 | 1.417E-01 | CYP1A2, CYP3A4 |
MF | GO:0005488; binding | GO:0044877; macromolecular complex binding | 2.119E-04 | 2.255E-01 | ACHE, MAPT, PPARA, TLR2 |
CC | GO:0043226; organelle | GO:0043231; intracellular membrane-bounded organelle | 1.759E-03 | 3.618E-01 | ACHE, CYP1A2, CYP3A4, MAPT, PPARA, TDP1, TLR2 |
CC | Unclassified; | GO:0106003; amyloid-beta complex | 3.980E-03 | 4.952E-01 | TLR2 |
CC | GO:0044464; cell part | GO:0030673; axolemma | 5.785E-03 | 5.942E-01 | MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |